Scott Vrieze

Scott Vrieze

Auto-generated profile, based on publicly available information

Scott Vrieze

Department of Psychology, University of Minnesota

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2019 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
MLMengzhen Liu
Mengzhen Liu
YJYu Jiang
Yu Jiang
RWRobbee Wedow
Robbee Wedow
YLYue Li
Yue Li
DBDavid M. Brazel
David M. Brazel
HPHunt All-In Psychiatry
Hunt All-In Psychiatry

26 November 2018 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
RWRaymond K. Walters
Raymond K. Walters
RPRenato Polimanti
Renato Polimanti
EJEmma Johnson
Emma Johnson
JMJeanette N. McClintick
Jeanette N. McClintick
MAMark J. Adams
Mark J. Adams
AAArpana Agrawal
Arpana Agrawal

7 December 2022 in Nature
Verified
Journal Article
Open access
PDF file
GSGretchen R. B. Saunders
Gretchen R. B. Saunders
XWXingyan Wang
Xingyan Wang
FCFang Chen
Fang Chen
SJSeon-Kyeong Jang
Seon-Kyeong Jang
MLMengzhen Liu
Mengzhen Liu
TPThe Biobank Japan Project
The Biobank Japan Project
Tobacco and alcohol use are heritable behaviours associated with 15% and 5.3% of worldwide deaths, respectively, due largely to broad increased risk for disease and injury1–4. These substances are used across the globe, yet genome-wide association studies have focused largely on individuals of European ancestries5. Here we leveraged global genetic diversity across 3.4 million individuals from four major clines of global ancestry (approximately 21% non-European) to power the discovery and fine-mapping of genomic loci associated with tobacco and alcohol use, to inform function of these loci via ancestry-aware transcriptome-wide association studies, and to evaluate the genetic architecture and predictive power of polygenic risk within and across populations. We found that increases in sample size and genetic diversity improved locus identification and fine-mapping resolution, and that a large majority of the 3,823 associated variants (from 2,143 loci) showed consistent effect sizes across ancestry dimensions. However, polygenic risk scores developed in one ancestry performed poorly in others, highlighting the continued need to increase sample sizes of diverse ancestries to realize any potential benefit of polygenic prediction.

26 August 2021 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
RLRichard Karlsson Linnér
Richard Karlsson Linnér
TMTravis T. Mallard
Travis T. Mallard
PBPeter Barr
Peter Barr
SSSandra Sanchez-Roige
Sandra Sanchez-Roige
JMJames W. Madole
James W. Madole
DDDanielle Dick
Danielle Dick

7 June 2021 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
BCB. Chaarani
B. Chaarani
SHS. Hahn
S. Hahn
NAN. Allgaier
N. Allgaier
SAS. Adise
S. Adise
MOM. M. Owens
M. M. Owens
TCthe ABCD Consortium
the ABCD Consortium

3 November 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
BQBryan C. Quach
Bryan C. Quach
MBMichael J. Bray
Michael J. Bray
NGNathan C. Gaddis
Nathan C. Gaddis
MLMengzhen Liu
Mengzhen Liu
TPTeemu Palviainen
Teemu Palviainen
DHDana B. Hancock
Dana B. Hancock
Cigarette smoking is the leading cause of preventable morbidity and mortality. Genetic variation contributes to initiation, regular smoking, nicotine dependence, and cessation. We present a Fagerström Test for Nicotine Dependence (FTND)-based genome-wide association study in 58,000 European or African ancestry smokers. We observe five genome-wide significant loci, including previously unreported loci MAGI2/GNAI1 (rs2714700) and TENM2 (rs1862416), and extend loci reported for other smoking traits to nicotine dependence. Using the heaviness of smoking index from UK Biobank (N = 33,791), rs2714700 is consistently associated; rs1862416 is not associated, likely reflecting nicotine dependence features not captured by the heaviness of smoking index. Both variants influence nearby gene expression (rs2714700/MAGI2-AS3 in hippocampus; rs1862416/TENM2 in lung), and expression of genes spanning nicotine dependence-associated variants is enriched in cerebellum. Nicotine dependence (SNP-based heritability = 8.6%) is genetically correlated with 18 other smoking traits (rg = 0.40–1.09) and co-morbidities. Our results highlight nicotine dependence-specific loci, emphasizing the FTND as a composite phenotype that expands genetic knowledge of smoking.